z-logo
open-access-imgOpen Access
Ischaemic stroke in a patient on sunitinib
Author(s) -
Maire Therese Lonergan,
Feargal Kellehar,
Ray McDermott,
Rónán Collins
Publication year - 2010
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr.01.2009.1420
Subject(s) - sunitinib , medicine , renal cell carcinoma , stroke (engine) , thrombosis , vascular endothelial growth factor , oncology , vegf receptors , mechanical engineering , engineering
Concerns have been raised about possible theoretical risk of thrombosis and bleeding with sunitinib (anti-vascular endothelial cell growth factor agent) therapy used for treatment of metastatic renal cell carcinoma. We present the first case of stroke in an older man with metastatic renal cell carcinoma, on sunitinib therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here